| Outcome Measures: |
Primary: HbA1c change from baseline at week 24, Change From Baseline in Hemoglobin A1c (HbA1c) at week 24, Baseline and week 24 | Secondary: HbA1c change from baseline at week 4,week 12,week 40 and week 52, Change From Baseline in Hemoglobin A1c (HbA1c) at week 4,week 12,week 40 and week 52, Baseline, week 4, week 12, week 40 and week 52|FPG change from baseline at week 4, week 8, week 12, week 16, week 24, week 40 and week 52, Baseline, week 4, week 8, week 12, week 24, week 40 and week 52|Percentage of patients with HbA1c <7.0% and HbA1c <6.5% at week 24 and week 52, Baseline, week 24 and week 52|Percentage of patients required use of rescue therapy at week 24 and week 52, Baseline, week 24 and week 52|Fasting c-peptide change from baseline at week 24 and week 52, Baseline, week 24 and week 52|Insulin sensitivity change (calculated by HOMA-IS) from baseline at week 24 and week 52, Baseline, week 24 and week 52|eatic β-cell function change (calculated by HOMA-β ) from baseline at week 24 and week 52, Baseline, week 24 and week 52
|
